Inhibition of organic anion transporter (OAT) activity by cigarette smoke condensate

被引:9
作者
Sayyed, Katia [1 ,2 ]
Le Vee, Marc [1 ]
Abdel-Razzak, Ziad [2 ]
Fardel, Olivier [1 ,3 ]
机构
[1] INSERM, U1085, Fac Pharm, IRSET,UMR, 2 Ave Pr Leon Bernard, F-35043 Rennes, France
[2] Lebanese Univ, Fac Sci, EDST AZM Ctr LBA3B, Rafic Hariri Campus, Beirut, Lebanon
[3] Ctr Hosp Univ, Pole Biol, 2 Rue Henri Le Guilloux, F-35033 Rennes, France
关键词
Drug transporter; Cigarette smoke; Pharmacokinetics; Organic anion transporter; Heterocyclic amines; P-GLYCOPROTEIN FUNCTION; TOBACCO SMOKING; DRUG-COMBINATION; EPITHELIAL-CELLS; GENE-EXPRESSION; CANCER-CELLS; MULTIDRUG; CADMIUM; KIDNEY; MRP1;
D O I
10.1016/j.tiv.2017.06.014
中图分类号
R99 [毒物学(毒理学)];
学科分类号
100405 ;
摘要
Cigarette smoke condensate (CSC) has previously been shown to impair activity and expression of hepatic drug transporters. In the present study, we provided evidence that CSC also hinders activity of organic anion transporters (OATS), notably expressed at the kidney level. CSC thus cis-inhibited OAT substrate uptake in OAT1- and OAT3-transfected HEK293 cells, in a concentration-dependent manner (IC50 = 72.1 mu g/mL for OAT1 inhibition and IC50 = 27.3 mu g/mL for OAT3 inhibition). By contrast, OAT4 as well as the renal organic cation transporter (OCT) 2 were less sensitive to the inhibitory effect of CSC (IC50 = 351.5 mu g/mL and IC50 = 226.2 mu g/mL, for inhibition of OAT4 and OCT2, respectively). OAT3 activity was further demonstrated to be blocked by some single chemicals present in cigarette smoke such as the heterocyclic amines A alpha C (IC50 = 11.3 mu M) and PhIP (IC50 = 1.9 mu M), whereas other major cigarette smoke components used at 100 mu M, like nicotine, the nitrosamine NNK and the polycyclic aromatic hydrocarbons benzo(a)pyrene and phenanthrene, were without effect. AaC and PhIP however failed to trans-stimulate activity of OAT3, suggesting that they were not substrates for this transporter. Taken together, these data establish OAT? and OAT3 transporters as targets of cigarette smoke chemicals, which may contribute to smoking-associated pharmacokinetics alterations.
引用
收藏
页码:27 / 35
页数:9
相关论文
共 61 条
[1]  
Apiwattanakul N, 1999, MOL PHARMACOL, V55, P847
[2]  
Bijnsdorp IV, 2011, METHODS MOL BIOL, V731, P421, DOI 10.1007/978-1-61779-080-5_34
[3]  
BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3
[4]   Inhibition of SLC drug transporter activities by environmental bisphenols [J].
Bruyere, Arnaud ;
Hubert, Celine ;
Le Vee, Marc ;
Chedik, Lisa ;
Sayyed, Katia ;
Stieger, Bruno ;
Denizot, Claire ;
Parmentier, Yannick ;
Fardel, Olivier .
TOXICOLOGY IN VITRO, 2017, 40 :34-44
[5]   Drug transport by Organic Anion Transporters (OATs) [J].
Burckhardt, Gerhard .
PHARMACOLOGY & THERAPEUTICS, 2012, 136 (01) :106-130
[6]  
Burckhardt G, 2011, HANDB EXP PHARMACOL, V201, P29, DOI 10.1007/978-3-642-14541-4_2
[7]   Real-time polymerase chain reaction analysis of CYP1B1 gene expression in human liver [J].
Chang, TKH ;
Chen, J ;
Pillay, V ;
Ho, JY ;
Bandiera, SM .
TOXICOLOGICAL SCIENCES, 2003, 71 (01) :11-19
[8]   Inhibition of Human Drug Transporter Activities by the Pyrethroid Pesticides Allethrin and Tetramethrin [J].
Chedik, Lisa ;
Bruyere, Arnaud ;
Le Vee, Marc ;
Stieger, Bruno ;
Denizot, Claire ;
Parmentier, Yannick ;
Potin, Sophie ;
Fardel, Olivier .
PLOS ONE, 2017, 12 (01)
[9]   Theoretical basis, experimental design, and computerized simulation of synergism and antagonism in drug combination studies [J].
Chou, Ting-Chao .
PHARMACOLOGICAL REVIEWS, 2006, 58 (03) :621-681
[10]   Drug Combination Studies and Their Synergy Quantification Using the Chou-Talalay Method [J].
Chou, Ting-Chao .
CANCER RESEARCH, 2010, 70 (02) :440-446